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Abstract
The global burden of mortality and morbidity caused by traumatic brain injury (TBI) is significant, and the heterogeneity of TBI
patients and the relatively small sample sizes of most current neuroimaging studies is a major challenge for scientific advances
and clinical translation. The ENIGMA (Enhancing NeuroImaging Genetics through Meta-Analysis) Adult moderate/severe TBI
(AMS-TBI) working group aims to be a driving force for new discoveries in AMS-TBI by providing researchers world-wide with
an effective framework and platform for large-scale cross-border collaboration and data sharing. Based on the principles of
transparency, rigor, reproducibility and collaboration, we will facilitate the development and dissemination of multiscale and big
data analysis pipelines for harmonized analyses in AMS-TBI using structural and functional neuroimaging in combination with
non-imaging biomarkers, genetics, as well as clinical and behavioral measures. Ultimately, we will offer investigators an
unprecedented opportunity to test important hypotheses about recovery and morbidity in AMS-TBI by taking advantage of
our robust methods for large-scale neuroimaging data analysis. In this consensus statement we outline the working group’s short-
term, intermediate, and long-term goals.
Keywords Brain injury . Radiology . Open Science . Neurodegeneration . Rehabilitation . ENIGMA
Brain injury and the ENIGMA consortium
For over three decades, neuroimaging has played an important
role in the characterization and management of moderate-to-
severe traumatic brain injury (msTBI). Novel magnetic reso-
nance imaging (MRI) methods and image analysis techniques
have great potential to improve clinical assessment and guide
management and treatment following msTBI. For this to be
possible, we must first address a number of scientific and
practical challenges in our field. The vast heterogeneity of this
patient population with respect to injury causes and mecha-
nisms, neuropathology, and clinical or functional outcomes—
in combination with the relatively small sample sizes of most
current neuroimaging studies—pose significant barriers to sci-
entific progress and clinical translation.
The Enhancing Neuroimaging Genetics through Meta-
Analysis (ENIGMA) consortium offers a framework for
meta- and mega-analysis of neuroimaging data across sites.
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This framework has proven to be a successful environment for
studying other psychiatric and neurological populations, often
with sample sizes 10–30 times larger than those in typical
brain imaging studies (Bearden and Thompson 2017;
Thompson et al. 2020). In this consensus statement, we de-
scribe the aims and goals of the ENIGMA Adult1 msTBI
(AMS-TBI) working group that was initiated in 2018 as part
of ENIGMA Brain Injury, which is a collaboration of 10 TBI
working groups (Wilde et al. 2019; Fig. 1). The group consists
of scientists and clinicians from a wide-range of disciplines
and backgrounds, and we welcome new members from
around the world to join our efforts.
The ENIGMA AMS-TBI working group aims to 1) be a
driving force for new discoveries in AMS-TBI by providing
researchers with a comprehensive and effective framework
and platform for large-scale, cross-border collaboration and
data sharing. Moreover, we will 2) facilitate the development
and dissemination of multiscale and big data analysis pipe-
lines for harmonized analyses in AMS-TBI using structural
and functional MRI in combination with other imaging mo-
dalities, non-imaging biomarkers, genetics, as well as clinical
and behavioral measures. Ultimately, 3) we will offer investi-
gators an unprecedented opportunity to test important hypoth-
eses about injury neuropathology through recovery and mor-
bidity in msTBI by taking advantage of our robust methods
for large-scale data analysis. Below we outline the back-
ground and structure of ENIGMA AMS-TBI, the roles of
investigators, and the working group’s short, intermediate,
and long-term goals (Fig. 2).
Leveraging ENIGMA to address challenges
in AMS-TBI research
TBI is a major and increasing global health challenge, with
more than 50 million new cases estimated to occur worldwide
each year (5 to 20% are msTBI), and an ensuing disability that
is 2–3 times higher than the contribution from cerebrovascular
disorders or Alzheimer’s disease (GBD 2016 Neurology
Collaborators 2019; Maas et al. 2017). TBI is defined as an
alteration in brain function, or other evidence of brain pathol-
ogy, caused by an external force (Menon et al. 2010), includ-
ing blunt or penetrating trauma, acceleration-deceleration
forces or exposure to blast (Thurman and National Center
for Injury Prevention and Control (U.S.) 1995).
TBI is currently considered a chronic condition character-
ized by evolving changes which require precise disease phe-
notyping, both in the acute stage and during the individual’s
lifespan (Corrigan and Hammond 2013; Maas et al. 2017;
Masel and DeWitt 2010). Common measures of injury sever-
ity, typically based on the Glasgow Coma Scale (GCS) score
(Teasdale and Jennett 1974) alone, or in combination with
other clinical signs or imaging (e.g. Stein and Spettell 1995),
only partially capture the variability in cognitive, behavioral
and social outcomes at acute and chronic stages following
injury. In the early phase after injury, lower GCS score, older
age, pupil dilatation, hypoxia, hypotension, and CT classifi-
cations based on the size of lesions and the degree of midline
shift, provides some utility for predicting mortality and for
categorization of patients into very broad outcome groups
(Faried et al. 2018; Maas et al. 2013; Steyerberg et al. 2008).
However, this information is less valuable for evaluating pa-
tients presenting with less severe injuries or more fine-tuned
prognostication of long-term neurobehavioral outcome.
Indeed, often individuals with similar indicators of severity
and early clinical trajectories experience different outcomes
(Bigler et al. 2006; Lutkenhoff et al. 2019). Recovery and
community re-integration are further complicated by a num-
ber of interacting premorbid, clinical, demographic, and ge-
netic factors (Mollayeva et al. 2019).
An integrated scientific endeavor is required in AMS-TBI
research to address these challenges. This will require large
sample sizes drawn from a multi-modal approach which com-
bines neuroimaging, non-imaging biomarkers, psychological,
cognitive, and behavioral data. Recent developments in neu-
roimaging and computational algorithms offer powerful ap-
proaches to examine not only the overt behavior of individ-
uals, but also the brain structure, function, and neural compu-
tations that can give rise to diverse outcomes (Amyot et al.
2015). In addition, there is an unexploited potential of using
neuroimaging to inform clinicians about the optimal timing
and effects of interventions for individual patients.
In recent years, neuroscientists have encountered problems
in the replication of published human neuroimaging studies,
especially those based on functional neuroimaging (Poldrack
et al. 2017). Many believe that this may be due to small effect
sizes; the median statistical power in neuroscience studies has
been estimated to be between 8 and 31% (Button et al. 2013).
One solution has been to increase sample sizes (Carter et al.
2016; Szucs and Ioannidis 2017). Large-scale collaborative
studies are therefore important to move the field of TBI for-
ward (Maas et al. 2017; Tosetti et al. 2013). Standing on the
shoulders of successful large-scale initiatives in TBI research
such as the TRACK-TBI (https://tracktbi.ucsf.edu/)
consortium in the US, the CREACTIVE (http://creactive.
marionegri.it/) and CENTER-TBI (www.center-tbi.eu; see
Steyerberg et al. 2019) collaborations in Europe, our
ENIGMA working group will offer a new platform and
framework for researchers to make neuroimaging more
useful for understanding AMS-TBI.
By offering our framework and methods to the larger re-
search community, we also aim to unlock the enormous po-
tential of analyzing dormant and unpublished “long tail” im-
aging data (see Fig. 3a,b; Hawkins et al. 2019), which are not1 Adult in this context is broadly defined as >16 years old.
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being leveraged as part of any coordinated, collective effort
(Fig. 3a). Long-tail or “dark data” are data that accumulate in
labs after a specific study finding is either interpreted and
published through a single study-specific lens or unpublished
and then archived. Consequently, there is great potential to
integrate and harmonize such data in unique and creative
ways. A central goal for our working group is to provide
methodological tools to integrate these datasets from TBI labs
around the world (Fig. 3b).
In the long term, methodologies developed as part of the
ENIGMA AMS-TBI initiative may have broader impact that
go beyond research imaging. The lessons learned by integrat-
ing data and finding imaging biomarkers with diagnostic,
prognostic and therapeutic significance should inform the de-
velopment of management protocols by clinicians and product
development in the biomedical industry. These advances
could specifically enhance the use of neuroimaging in the
clinical management of TBI through 1) the development and
validation of clinically useful methods for analysis that ac-
commodate both high- and low-end imaging protocols (in-
cluding legacy data), and 2) by informing the development
of a future core clinical imaging dataset for TBI, with acqui-
sition parameters and data structure established by broad con-
sensus, that could be harmonized across vendors. Given that
the clinical use of MRI dwarfs data acquired for research by
several orders of magnitude, such harmonization (which is
already occurring in some research contexts, e.g. Alfaro-
Almagro et al. 2018; Wiberg et al. 2019) would make very
large datasets accessible to research. Collation and integration
of such “non-research” clinical imaging for research could
Fig. 1 The ENIGMA consortium and the Brain Injury working group. Organization and current geographical representation in the ENIGMA consortium
and the ENIGMA Brain Injury working group. Adapted from Thompson et al., 2020 and Wilde et al. 2019
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deliver analyses that involve datasets with n > 100,000. There
are clear regulatory barriers and consent hurdles that need to
be addressed before such data were freely available for
research (Anderson 2015; Benchimol et al. 2015). However,
authoritative views suggest that fully anonymized clinical im-
aging data can be used for research purposes with appropriate
safeguards (The Royal College of Radiologists 2017), and
such use of data may be further facilitated by federated anal-
yses of data, where the research pipelines are brought to the
data (rather than vice versa), both for structural and functional
imaging (X. Li et al. 2020; Silva et al. 2019).
Fig. 3 The long tail and dark data for traumatic brain injury (TBI)
research. The current state of TBI data consists of a relatively small
number of large, publicly accessible datasets reflected schematically as
a right-skewed distribution (Panel a). The majority of data collected by
the field exists in the long tail of the distribution, with most datasets
consisting of relatively modest data sizes as either gray data that are
difficult to access beyond summaries reported in publications; or dark
data that are inaccessible or archived. b The goal is to make TBI
imaging data Findable, Accessible, Interoperable, and Reusable (FAIR,
Wilkinson et al., 2016) thereby shortening the long tail of dark data, and
making a greater proportion of the data in the TBI literature publicly
accessible to drive new discoveries and accelerate translation. (Adapted
from Hawkins et al., 2019)
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Fig. 2 Goals of ENIGMA AMS-
TBI. Schematic presentation of
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term goals of the ENIGMA
AMS-TBI working group
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Short-term goal: Forming ENIGMA
AMS-TBI—Its structure and methodological
framework
Our short-term goal (1st year) is to identify datasets and recruit
researchers as members by providing an attractive platform and
framework for global large-scale cross-border collaboration, data
sharing, and analysis. A strength of ENIGMA AMS-TBI is our
emphasis on supporting the TBI research communitywith robust
methods and analyses, and the goal to advance brain imaging
science in neurotrauma through the principles of transparency,
rigor, reproducibility, and collaboration.
For ENIGMA AMS-TBI, there is a low threshold for par-
ticipation (data sharing is not required), allowing individual
researchers to choose to participate at different levels depending
on their interests and/or situation. There are a number of differ-
ent ways researchers can participate, these include:1) mega-
analyses (sharing raw data or numerical output from such data),
2) meta-analyses (no need to share raw data), and 3) methods
and protocol development (no need to participate with data).
We welcome proposals from the TBI research community at
large, and we will serve as a hub for investigators who could
benefit from the ENIGMA structure. In addition to working
with existing datasets, we will provide a platform for re-
searchers to collect and harmonize future studies. Most data
acquired to date have been collected using diverse protocols.
Members of the group are developing protocols for future data
collection, to enable prospective harmonization within individ-
ual cohort studies, thereby allowing members to participate in
future multicenter initiatives at low additional cost and effort. It
would be critically important, in this context, to ensure that we
start with what is most universally implementable, and identify
a core set of sequences and data collection for widespread use.
As with the NINDS Common Data Elements (CDEs; https://
www.commondataelements.ninds.nih.gov/Traumatic%
20Brain%20Injury#pane-162) it may be useful to also provide
more aspirational imaging standards as basic and supplemental
- thus allowing optional use of more complex harmonized im-
age collection, if appropriate and possible.
The AMS-TBI working group will benefit greatly from the
established procedures, methods, and analytic pipelines that
have engendered success across the larger ENIGMA consor-
tium including more than 1400 scientists across 43 countries
and more than 20 psychiatr ic, neurological , and
neurodevelopmental disorders (Thompson et al. 2020).
Extending prior efforts, we will develop a comprehensive set
of protocols, procedures and open source code for data analysis
tailored for tackling major challenges in msTBI imaging. Part of
this effort can be found in previous ENIGMA programs, which
have developed imaging analysis pipelines to extract, homoge-
nize, and control the quality of data describing standardized
phenotypes from structural T1-weighted MRI, diffusion MRI,
resting state functionalMRI and EEG (Adams et al. 2016; Bis et
al. 2012; Boedhoe et al. 2017; Guadalupe et al. 2017; Hibar et
al. 2016; Hibar et al. 2017, 2015; Hoogman et al. 2017; Ikram et
al. 2012; Jahanshad et al. 2013; Schmaal et al. 2016; Stein et al.
2012; van Erp et al. 2016).
One strength of ENIGMA is the focus of researcherswithin
the consortium to develop standardized data processing pipe-
lines for handling distinct data types. Much of the variability
in research comes from investigators decisions in data pro-
cessing and analysis, referred to as “researcher degrees of
freedom” (see Nichols et al. 2017). In modern neuroimaging,
these degrees of freedom can be readily found in analyses of
both structural and functional imaging data (Hallquist and
Hillary 2019). To standardize approaches for data pre-pro-
cessing, in particular for functional imaging data pipelines,
we plan to integrate members of the international community
conducting AMS-TBI work to investigate how to best harmo-
nize and standardize such methods and provide quality con-
trol. Overall, the goal for our ENIGMA working group is to
act as a forum where AMS-TBI scientists can interact and
collaborate, and where consensus on methods can evolve
and become suitable for the larger scientific community.
Participating members are encouraged to adhere to the FAIR
Data Principles (Findable, Accessible, Interoperable, Reusable),
to enhance the usability of data (Wilkinson et al. 2016). Primary
data, derived data, and other research outputs such as protocols,
source code and software, if well documented, accompanied by
descriptive metadata and organized in a standardized way, are
likely to foster collaboration and reproducibility. An example of
a relevant data repository for publishing data in neuroimaging is
OpenNeuro (https://openneuro.org), which uses the Brain
Imaging Data Structure (BIDS) format for organizing data
(https://bids.neuroimaging.io). By adhering to relevant
standards, harmonizing analysis tools and sharing data as open
as possible, possibilities for reuse, reproducibility, as well as
meta- and mega-analysis greatly increase, both within
ENIGMA and in the greater research community.
The ENIGMA AMS-TBI working group will provide sup-
port to members on regulatory issues based on accumulated
knowledge and available expertise within the network. When
combining different data for analysis, there are many levels of
sharing, ranging from sharing the raw data, to sharing quanti-
tative measures and features extracted from imaging scans, to
sharing only meta-data. It is important to consider the type of
data to be shared and the local (institutional, national or inter-
national) rules and regulations that need to be followed. There
is, therefore, not a single approach, and each participating site
needs to abide by appropriate regulations. Our members have
extensive experience in dealing with such issues, not only
from participation in other ENIGMA groups, but also through
participation in other large-scale international TBI collabora-
tions (e.g., CENTER-TBI).
Working group chairs provide leadership to support re-
searchers in achieving planned objectives. Our approach is
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based on the principles of team science and our success is
expected to be driven by the collective coordinated effort of
participating researchers. Building on years of experience from
ENIGMA, we have developed a group-specific memorandum
of understanding (MOU), with policies for data sharing, author-
ship, and for initiating new studies. Communication within the
group will largely involve teleconferences with alternating
scheduling to accommodate members across different time-
zones, in addition to face-to-face meetings, often in connection
with international conferences.
Intermediate goal: Provide tools for improved
lesion mapping and clinical, cognitive
and behavioral phenotyping in AMS-TBI
Our intermediate goal (1–2 years) is to support two overarch-
ing projects to address key challenges linked to the heteroge-
neity of msTBI which will benefit all future ENIGMA AMS-
TBI projects. The first project will focus on developing im-
proved methods for lesion characterization, mapping, and
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harmonization of measures across sites to allow for improved
clinical, cognitive, and behavioral phenotyping. This will pro-
vide the research community with important methods to di-
rectly address two of the main challenges regarding clinico-
pathological heterogeneity in msTBI. These projects will also
serve as important vehicles to motivate researchers to join our
early efforts, and for consolidating our working group.
Standardization of image analysis protocols for AMS-TBI:
Improved methods for lesion characterization, mapping,
and quantification Our working group will aim to provide
standardized best practices (e.g. Nichols et al. 2017) for mul-
timodal neuroimaging analysis in AMS-TBI. This need is
critical partly because analyzing MRI scans from AMS-TBI
patients poses unique challenges from the standpoint of lesion
mapping, pathology characterization, and clinical interpreta-
tion (see Fig. 4). The heterogeneity of lesion profiles (e.g,
biomechanical cause, type of pathology, location, or volume)
frequently makes automatic MRI analysis pipelines break
down or fail due to causes that frequently include (but are
not exclusive to) inaccurate co-registration of scans across
modalities and time points, faulty voxel-wise morphometric
analysis, and incorrect automatic parcellations of brain struc-
tures (Irimia et al. 2014).
Our working group will aim to propose, implement and
validate standards to facilitate such operations and to enhance
their reproducibility. Even relatively “simple” image process-
ing steps like “skull-stripping” - which is required for many
processing pipelines and brain co-registration - tend to fail
when using conventional software on images from patients
Fig. 4 The complexity of lesion characterization and behavioral phenotyping after AMS-TBI. From a structural neuroimaging perspective trauma-
induced abnormalities differ by time post-injury as well as the imaging modality being used. a are all CT based showing that the size and location of the
hemorrhage, parenchymal displacement and edema dynamically change over time. b demonstrates that each MRI sequence has its own unique
sensitivity in assessing different aspects of neuroanatomy and neuropathology. c which presents the FLAIR, SWI and T1 signal abnormalities,
demonstrates the widespread pathology differently presented by these imaging methods. By 5 months’ post-injury, widespread volume loss, cortical
atrophy, ventriculomegaly and encephalomalacia have occurred. d show summary findings from a neuropsychological assessment at ~8 months post
injury. This case example depicts the neuropathological heterogeneity associated with TBI along with the dynamic changes over time and their influence
on neuropsychological test results. This patient sustained a severe TBI from a motorcycle collision with a vehicle. The patient was not helmeted at the
time of injury and, by witness accounts, was immediately rendered unconscious. Upon emergent care at the scene of the accident, the patient was
assessed to have a Glasgow Coma Scale (GCS) of 3, was life-flighted to a Level I emergency department (ED) with GCS remaining 3 throughout
transport and during ED assessment and treatment. In addition to the head injuries he sustained multiple systemic injuries including leg and rib fractures,
pulmonary contusion and liver laceration. An intracranial pressure monitor was inserted, the patient underwent tracheostomy for airwaymanagement and
shunted. The patient remained in a coma and received neurocritical care for almost 2 months, followed by 3 months of inpatient neurorehabilitation. a
Initial day-of-injury computed tomography was performed about 90 min’ post-injury. What is important to note in the initial scan is the original size of
the frontal intraparenchymal hemorrhage along with the size, symmetry and configuration of the ventricular system. Within 24 h, enlargement of the
intraparenchymal hemorrhage is observed along with distinct effacement of the anterior horn of the lateral ventricle and surrounding edema associated
with the hemorrhage. Subsequent to this scan he was shunted, with the shunt catheter clearly visible in the 2-week follow-up scan which depicts more
edema and midline shift. By 5 months’ post-injury, there is prominence of the ventricular system and cortical sulci in association with cortical atrophy
and frontal encephalomalacia associated with the location of the prior hemorrhage. b At 2 weeks post-injury,MRI studies were obtained. Each sequence
demonstrates a different aspect of the “Lesion.” The T1 sequence, which is the one commonly used for automated methods of image segmentation and
classification for quantitative analyses, depicts coarse anatomical features of the brain, but the focal intraparenchymal hemorrhage and surrounding
edema is not fully appreciated, being better distinguished by the T2 and FLAIR sequences. The SWI sequence depicts multiple, bilaterally scattered foci
of hemosiderin deposition reflective of shear injury, with particularly exquisite demarcation differentiating hemorrhage, parenchymal degradation along
with the surrounding edema. c Using a thresholding method for detecting white matter signal abnormality in FLAIR scans, the regions of white matter
hyperintensity are depicted three dimensionally in the images on the left. Each signal abnormality likely reflects localized white matter pathology. In the
middle are the regions of hemosiderin deposition detected on SWI, likewise reflecting specific foci of shear-lesion pathology constituting diffuse axonal
injury. On the right are the abnormalities found on T1. d Findings from neuropsychological assessment at almost 8 months post injury are presented as z-
score deviations from test manual normative data. The following tests were administered: Repeatable Battery for the Assessment of Neuropsychological
Status (RBANS, https://www.pearsonassessments.com/), Rey Complex Figure Test (RCFT, https://www.parinc.com), California Verbal Learning Test-
II (CVLT-II, https://www.pearsonassessments.com/), Delis-Kaplan Executive Function System (D-KFES, https://www.pearsonassessments.com/);
Symptom Checklist-90 (SCL-90, https://www.pearsonassessments.com/) and the Behavioral Rating Inventory of Executive Function (BRIEF, https://
www.parinc.com). Clinically, the 25-year-old presented with left side hemiparesis, emotional lability and major cognitive impairments, most notable in
terms of memory and executive functioning. Family and caregivers were most concerned about the patient’s irritability and inappropriate outbursts along
with impaired insight and judgment. Neuropsychological tests (lower z-scores = poorer function) demonstrated the expected left side reductions in motor
control (reduced finger tapping and grip strength) consistent with the location of the large intraparenchymal right frontal hemorrhagic injury (see Fig. 4a-
c). He was anosmic and unable to identify basic odors on the Smell Identification Test (https://sensonics.com/) along with diminished tactile
discrimination on the left side, but no visual field defect. Constructional praxis was diminished as evident in the copy of the Rey Complex
Figure Test (RCFT), with the more profound deficits most notable with impaired immediate as well as delayed memory. Memory and executive
impairments were evident on the RBANS, CVLT-II and DKFES tasks. Caregiver observation, based on the BRIEF (higher z-scores = more
problems) also confirmed real-world deficits in day-to-day impairments in planning, organization, decision making and problem solving.
Emotionally, as also reflected in the BRIEF results, the family caregiver reported marked dysfunction in emotional regulation with poor self-
monitoring and impaired insight. In contrast, on the SCL-90 (higher z-scores = more symptoms), which is a self-report measure, while somatic issues
that related to mobility and pain were prominently endorsed, the Global Severity Index (GSI) was only minimally elevated, with no significant
endorsement of symptoms related to depression or anxiety. This would be consistent with caregiver observations that the patient lacked insight into
changes in personality and emotional control, impairments often reported to be present in TBI patients with extensive frontotemporal pathology (Krudop
& Pijnenburg, 2015), as evident in this patient
R
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with TBI, and require customized pipelines (Lutkenhoff et al.
2014). Conventional lesion mapping approaches - such as
pathology masking - can fail, especially when multiple large
lesions are present (Wong et al. 2016). This is partly because
masks frequently classify voxels from different lesion types
identically regardless of their presentation on MRI, and dis-
card potentially valuable information on lesion type and loca-
tion, factors that may have prognostic utility (B. Wang et al.
2013). Furthermore, lesion masks do not convey either the
pattern or the extent of injury-related brain deformations. As
a result, careful testing and validation—including visual in-
spection by neuroradiologists—can be necessary even when
masking techniques have been validated on systematic
lesioning data sets. There has been growing interest in using
machine learning (ML) to improve anatomical parcellation
(Ledig et al. 2015) and lesion detection based on computed
tomography (CT) (Jain et al. 2019) and anatomical MRI
(Kamnitsas et al. 2017) in AMS-TBI patients. Combining
such methods with large databases of systematic lesions
(Wang et al. 2013) may be particularly advantageous for
connectome analysis (Irimia and Van Horn 2014) or when
the alternative involves laborious manual delineation. One
aim of our working group will be to propose detailed proce-
dures to integrate information from different sources and
methods and to provide guidelines on their use.
As an example, we aim to provide distinct lesion mapping
decision trees that accommodate the availability—or partial
lack—of MRI scans acquired using various sequences, includ-
ing T1-weighted (T1w), susceptibility weighted imaging (SWI),
and fluid-attenuated inversion recovery (FLAIR) scans. TBI le-
sion characterization is a complex inferential process, which
aims to identify the lesion’s content, physical properties and
evolution based on complementary information from a variety
of MRI modalities. After image preprocessing, distinct MRI
modalities can be used to extract unique information on the
physical content, pathophysiological state or likely longitudinal
trajectory of each lesion-confined voxel (Wang et al. 2013). For
example, the T1wMRI contrast is indicative of the content of fat,
whereas FLAIR hyperintensities are linked to the localized tis-
sue water content (e.g. suggesting vasogenic edema or
perivascular CSF). By contrast, SWI hypointensities results
from the presence of (i) ferromagnetic hemoglobin in the lumina
of blood vessels and (ii) extravasated ferromagnetic material in
the cerebral parenchyma. Consequently, lesion description can
be challenging in AMS-TBI because inferringMRI signal prov-
enance does not equate straightforwardly to the characterization
of pathobiology. For this reason, when lesion-related informa-
tion is made available from fewer—rather than more—
information channels, subtle yet consequential issues of inter-
pretability and diagnosis may arise. To address such difficulties,
our working group will aim to formulate a detailed protocol and
implement conservative guidelines for lesion mapping, quanti-
fication and characterization based on the rigorous
understanding and interpretation of the available MRI sequence
modalities and on their correct joint interpretation.
Harmonizing protocols for improved clinical, cognitive, and
behavioral phenotyping through large-scale datasets
Accurate patient diagnosis and prognostication, with respect
to clinical, cognitive, and behavioral outcomes, is paramount
within the TBI field. A sound clinical evaluation of an indi-
vidual patient includes information about premorbid factors,
injury-related variables, and broad clinical and functional as-
sessments that are integrated and appropriately interpreted or
formulated (see Fig. 4). In the scientific literature, only general
associations have emerged between premorbid, clinical, and
demographic factors and subsequent outcomes (Ponsford et
al. 2008; Spitz et al. 2012; Wood and Rutterford 2006). For
example, history of emotional disturbance, older age, and
higher severity of injury generally lead to poorer functional
outcomes (Hoofien et al. 2001; Spitz et al. 2019). More re-
cently, there has been significant investment in identifying
reliable biomarkers to aid in the initial diagnosis and charac-
terization of TBI and prediction of future outcomes, ultimate-
ly, to enable tailored clinical interventions (“Precision
Medicine”). This quest has included physiological and neuro-
imaging measures.
Group-level results suggest that anatomical and functional
alterations to the brain generally correlate with changes in
cognition and behavior (e.g. Bonnelle et al. 2012; Brezova
et al. 2014; Håberg et al. 2015; Kinnunen et al. 2011; Olsen
et al. 2015). Brain changes have been characterized with re-
spect to loss in regional volume, altered white-matter micro-
structure, functional connectivity and brain activation. Despite
the application of advanced neuroimaging techniques to TBI,
including diffusion-weighted imaging and functional connec-
tivity analyses that can reveal subtle brain changes, the vast
majority of the variability in outcomes remains unexplained.
This situation clearly highlights the problem of heterogeneity
in TBI outcomes and raises the need for ENIGMA-type large-
scale research projects. The lack of reliable predictive bio-
markers hamper the development of disease-modifying thera-
pies. Moreover, there is difficulty in translating results obtain-
ed at the group-level to the individual, likely due to large
variability in regard to patient preinjury/genetic profile, demo-
graphics, injury mechanism, type and location and post-injury
interval/phase (Fisher et al. 2018; Moen et al. 2016; Molenaar
et al. 2009). Failure to deduce facts from groups to individuals
is probably a major factor explaining the failure of therapeutic
interventions (L. M. Li et al. 2014; Saatman et al. 2008).
Therefore, accurate individual-specific diagnosis must pre-
cede the development of effective treatments.
The problem of heterogeneity is not unique to TBI. Many
other fields—for example, psychiatry—also face the ‘hetero-
geneity problem’ (Feczko et al. 2019); 1) that any outcome or
constellation of symptoms is not caused by a single
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mechanism, but is the result of variable combinations of
known and unknown factors; and 2) that our way of measur-
ing individual outcomes influences how we determine the
relevant contribution of the potential mechanisms. For exam-
ple, MRI measures that best diagnose TBI may differ from
those that best predict development of emotional disturbance,
or manifestation of any other behavior, following TBI.
Defining adequate, clinically relevant, and agreed-upon out-
come measures poses a serious challenge. The interagency
Traumatic Brain Injury Outcomes Workgroup addressed pri-
marily clinical research objectives (Hicks et al. 2013; Wilde et
al. 2010). The rationale behind the coremeasures was the need
to create a primary set of well-established measures that ad-
dress outcome domains in many studies. This group sought to
identify a single measure or limited set of measures that best
represented each domain. One of the primary objectives was
to facilitate comparability of outcome measurements across
studies. Important efforts such as the Common Data
Elements (CDE) initiative have provided some direction for
researchers for selecting CDEs linked to demographics, acute
clinical assessment, neuroimaging, biomarkers/specimens and
outcome measures (Duhaime et al. 2010; Thurmond et al.
2010; Yue et al. 2013). Also, the Traumatic Brain Injury
Endpoints Development (TED) Initiative aims to provide har-
monization of study measures across eight major TBI studies
(Manley et al. 2017). However, most existing msTBI studies
do not adhere to the CDEs or other standards. ENIGMA
AMS-TBI will work with existing initiatives focusing on pro-
spective or retrospective harmonization of measures and data
across studies with an aim to contribute to a global solution to
this challenge.
One avenue for tackling the challenge of heterogeneity is
by leveraging large-scale collaborative initiatives. The
ENIGMA AMS-TBI working group offers: a) the ability to
standardize quality assurance (QA) and imaging protocols
across sites; b) the potential for harmonization of current and
future demographic, clinical, and behavioral measures across
sites. This will be accomplished by finding CDEs across
cohorts—what measures have most commonly been collected
and offer the most overlap across sites. Incorporated into this
pipeline will be methods that handle, compare, and impute
missing information from existing data; c) an open discussion
forum to establish a consensus regarding relevant and appro-
priate measures for diagnosis as well as prognosis within
msTBI. The inclusion of clinicians and clinical researchers
in the ENIGMA AMS-TBI initiative will contribute to sound
discussions of what behavioral, cognitive and other psycho-
logical outcome measures are most likely to provide the most
relevant optimal benchmark for imaging data; and d) given the
larger sample size, the ability to begin using new tools and
techniques to better examine clinical, cognitive, and behavior-
al phenotypes or subgroups of patients. Advances in compu-
tational and machine learning approaches may hold a
transformative potential to more accurate patient classification
opening avenues toward a more personalized medicine in
AMS-TBI. Our ENIGMA AMS-TBI initiative will facilitate
these goals (a–d) and even allow for collection of new data as
a consortium to fill gaps or deepen phenotyping.
Long-term goal: ENIGMA as a sustainable
and driving force for new discovery
in AMS-TBI
Our long-term goal (>2 years) is to be fully engaged with the
broader TBI research community and support researchers in
tackling important research questions in AMS-TBI, focusing
on the unique contributions of big data approaches. We expect
the ENIGMA strategy to be ideally suited to particular re-
search questions and our early efforts will leverage our prima-
ry strengths of data sharing and methods development. Here,
we outline a number of areas where we have current expertise
within ENIGMA AMS-TBI, and where we believe our ap-
proach has a lot of potential for high gains in the field.
Examples are provided recognizing that our group is in its
early phase, anticipating that the approaches and initiatives
will be shaped further by existing and new members.
Conducting international replication/reproducibility effort in
AMS-TBIWith the replication crisis that emerged in the social
sciences in 2015 (Maxwell et al. 2015; Open Science
Collaboration 2015) and expanded to nearly every corner of
science, including the neurosciences (Button et al. 2013) there
have been recent efforts to galvanize the community around
specific processing pipelines (see Esteban et al. 2019). In con-
cert with these efforts we aim to work with the international
community to leverage the power of data sharing in order to
identify the most robust findings in the TBI literature.
To do so, the ENIGMA AMS-TBI aims to establish reli-
able findings in the imaging and genetics community that can
serve as anchors to the field. From these vantage points, the
science of TBI can then advance on a firmer scientific footing.
Given the range of possible premorbid and injury-related fac-
tors that influence the central neural system (CNS) and its
functions (behavior), there remain great challenges in the
study of reproducibility in TBI research. The promise this
effort holds, however, is to determine if key findings emerging
from the imaging literature are generalizable across sites and
samples, thus providing investigators with a foundation from
which they can work. Establishing those reliable findings is
vital for the advancement of our understanding of the conse-
quences of TBI on neural systems and patient outcomes. The
ENIGMA AMS-TBI working group will vet the first genera-
tion of replication studies with the TBI community and begin
designing analyses based upon data currently existing
amongst our collaborators. Moreover, we invite investigators
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in the TBI research community to propose critical topics that
require replication and can be supported by the ENIGMA
AMS-TBI working group. Establishing the reproducibility
of our science is a core agenda item for the ENIGMA AMS-
TBI working group.
Acute/early MRI for guiding intervention and prognosis
While CT imaging will continue to play an important role in
clinical decision-making in the acute treatment of AMS-TBI
(Irimia et al. 2019), increased attention has been given to the
clinical and prognostic value of acute/early MRI. Although
the optimal timing of MRI acquisition after AMS-TBI is still
unknown and may be both injury-specific and patient-specif-
ic, imaging does need to be performed early enough to inform
clinical decision making. Taking an acute patient for an MRI
scan from an intensive care unit (ICU) while under ventilation
can be challenging, but remains a vital means for assessment
when precautions are taken to ensure MRI compatibility and
safety (Carter et al. 2013; Newcombe et al. 2008; Newcombe
and Menon 2016).
EarlyMRI has been successfully implemented to assess the
presence and evolution of brain lesions due to trauma
(Newcombe et al. 2016, 2013). For example, the presence of
brainstem lesions has been linked to increased mortality and
unfavorable Glasgow Outcome Scale at 6 months (risk ratio,
1.78; 95% CI, 1.01–3.15; I = 43%) (Haghbayan et al. 2017),
while lesions involving the ascending arousal network may be
critically predictive of poor outcome (Izzy et al. 2017; Moe et
al. 2018). However, the accuracy and replicability of such
findings will benefit from the analysis of larger samples from
multiple sites. Additionally, greater exploration of the func-
tional impact of injury to additional brain regions and the
manner in which the same regions are impacted across imag-
ing modalities is needed.
In addition to prognosis, acute/early MRI may provide key
information on the pathophysiological processes of specific
lesion types. Contusions in TBI tend to have distinct regions:
a core of restricted diffusion associated with hematoma,
surrounded by an area of raised apparent diffusion coefficient
(ADC) likely to be due to vasogenic edema, and in earlier
scans (within 72 h) an outer rim of ADC hypointensity that
is later subsumed by the vasogenic edema (Newcombe et al.
2013). This outer rim may represent a region of microvascular
failure resulting in cytotoxic edema, and may represent a
“traumatic penumbra” which may be rescued with effective
therapy. Indeed, in such “at-risk” regions of metabolically
compromised tissue, normobaric hyperoxia has been shown
to increase oxygen utilization using 15O PET and, thus, may
help save the metabolically compromised tissue (Nortje et al.
2008). This is consistent with a subsequent study which found
that normobaric hyperoxia may pseudo-normalize the ADC in
the cytotoxic rim (Veenith et al. 2014). Acute and early clin-
ical MRI, in conjunction with carefully executed experimental
animal studies, can also shed light on the mechanisms under-
lying msTBI (Lutkenhoff et al. 2019). Moreover, the value of
early MRI is not limited to structural scans. For example, a
functional MRI study in patients with post-traumatic amnesia
found evidence of disconnection between the medial temporal
lobes and the default mode network (De Simoni et al. 2016).
ENIGMA AMS-TBI will work on improved methods to de-
lineate the optimal timing of MRI after AMS-TBI and to fur-
ther identify and refine lesion patterns yielding important
prognostic information which can guide clinical decision-
making.
Imaging disorders of consciousness (DOC) after TBI Progress
in intensive care medicine has led to a large increase in the
proportion of patients who survive msTBI (Laureys and Boly
2008; Masel and DeWitt 2010). A majority of AMS-TBI sur-
vivors enter a transient state of coma, which is generally con-
sidered to resolve within 3 to 4 weeks (Young 2009), to then
spontaneously regain the two cardinal elements of conscious-
ness: arousal and (self-)awareness (Laureys 2005).
Conventional structural MRI, DTI, and fMRI can provide
added prognostic accuracy to the clinical observations and
CT imaging in predicting which patients will emerge from
coma (Snider et al. 2019; Stevens et al. 2014). A small
number of patients with very severe TBI (Beaumont and
Kenealy 2005; Løvstad et al. 2014; van Erp et al. 2015),
however, fail to fully regain consciousness and enter
(transiently or for prolonged and sometimes life-long periods)
into a vegetative (VS) or a minimally conscious state (MCS)
(cf., Giacino et al. 2002; Jennett and Plum 1972; Monti et al.
2010a). In the context of these three conditions (i.e., coma,
VS, MCS) - often referred to as Disorders of Consciousness
(DOC) - diagnosis and prognosis are a critical challenge
(Monti et al. 2009; Owen and Coleman 2008). In the absence
of an objective means of determining level of consciousness,
differentiating an MCS from a VS is an inferential process
(Giacino et al. 2014) which is known to be logically problem-
atic (cf., Monti and Owen 2010) and prone to misdiagnosis
(Schnakers et al. 2006, 2009). However, accurate diagnosis of
DOC is essential for medical management, prognosis, moni-
toring of interventions, as well as the complex legal and eth-
ical ramifications concerning end-of-life decisions. Over the
last 20 years, neuroimaging has revolutionized our under-
standing of these conditions (Lutkenhoff and Monti 2016).
Functional MRI has shown the ability to detect both residual
cortical processing and networks (e.g., Laureys et al. 2000;
Menon et al. 1998; Monti, Pickard, and Owen 2013; Owen
et al. 2005) and voluntary (brain) behavior (e.g., Bardin et al.
2011; Edlow et al. 2017; Monti et al. 2015; Monti et al.
2010b) in a minority sub-group of otherwise unresponsive
patients. 18F-FDG-PET has been shown, in a recent clinical
validation study (Stender et al. 2014), to be able to detect the
presence of awareness in DOC with greater sensitivity than
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fMRI (93%) and to predict long-term outcome with high ac-
curacy (74%).
While traditional readings of structural imaging data (e.g.,
CT, MRI) have shown limited utility in DOC, more advanced
analytical and imaging techniques yield greater promise in
their ability to uncover patterns of damage in large-scale brain
networks (Monti 2012; Schiff 2010), considered hallmarks of
DOC, and to differentiate between diagnostic categories.
Advanced (i.e., “shape”) analysis of routine T1-weighted data,
for example, has demonstrated a link between thalamic and
extra-thalamic subcortical atrophy and depth of impairment in
chronic DOC patients across etiologies (Lutkenhoff et al.
2015) - a pattern of atrophy which, at least in TBI, might take
shape in the first months post injury (Lutkenhoff et al. 2019;
Schnakers et al. 2019). Diffusion MRI can also help in quan-
tifying the structural integrity of white matter, and thus poten-
tially the primary and secondary network damage encountered
in DOC (Voss et al. 2006). Several recent studies suggest that
DTI-derived metrics of fractional anisotropy and diffusivity
may be useful in differential diagnosis through the identifica-
tion of the neural networks underlying the various levels of
impairment seen in DOC (Wu et al. 2016; Xu et al. 2017;
Zheng et al. 2017). Nonetheless, several gaps in the literature
and challenges in applying neuroimaging techniques to DOC
still remain (Cavaliere et al. 2014). Patients with prolonged
DOC are relatively few, and imaging these patients is chal-
lenging. Most imaging group studies of DOC are performed
on patients with mixed etiology (e.g., anoxia, stroke), despite
known differences across etiologies (Adams et al. 2000;
Adams et al. 1999; Giacino and Kalmar 1997; Graham et al.
2005; Lutkenhoff et al. 2015; Multi-Society Task Force on
PVS 1994). Our working group will provide a platform to
combine data from DOC patient groups across sites and de-
velop improved methods for using imaging in diagnosis and
outcome predictions which will be of great value for patients
and their caregivers.
Imaging in treatment and rehabilitation after msTBI Most
intervention studies report results at the group average level,
rendering little information on who might benefit from a re-
habilitation protocol or what might be the structural or func-
tional underpinnings of treatment efficacy. There is, however,
a growing literature using neuroimaging methods to assess
system-level plasticity as a result of specific rehabilitation
protocols (for a critical review, see Caeyenberghs et al.
2018), including efforts to develop biomarkers for motor
(Lima et al. 2011) and cognitive (e.g. Arnemann et al. 2015;
Chen et al. 2011; Chiaravalloti et al. 2015) change. Moreover,
using neuroimaging as decision aids in stratifying treatment
response and supporting treatment selection has a great poten-
tial. As an example, a recent study combining MRI and I-
ioflupane SPECT demonstrated that only TBI patients with
low caudate dopamine transporter levels had cognitive
improvements from methylphenidate treatment (Jenkins et
al. 2019).
There is a need for large, well-controlled studies that in-
clude neuroimaging data to better understand the neural un-
derpinnings of treatment efficacy and individual injury-related
factors (Vander Linden et al. 2018) that contribute to success
or failure of a given intervention. One goal of ENIGMA
AMS-TBI is to support analyses of effects of interventions
on broad cognitive processes even in the context of distinct
imaging and rehabilitation protocols. This approach will seek
to isolate the most robust main effects irrespective of between-
study differences, which may guide more nuanced work to
examine mechanisms. Currently, the only method to examine
main effects is to perform meta-analysis work limited to com-
bining studies by cognitive modality (e.g., interventions that
aim at improving memory or attention). However, such an
approach is still restricted by the absence of harmonization
in scanning protocols and outcome variables, potentially call-
ing for the use of data reduction techniques (such as explor-
atory principal component analysis on disparate neuropsycho-
logical data) and use of multiple covariates (sample size per-
mitting). Second, to understand the efficacy of distinct reha-
bilitation protocols across a range of behaviors (e.g., improve-
ments in attention and/or memory), we will facilitate prospec-
tive work by supporting data harmonization and analyses.
While there remain important challenges, data sharing offers
the opportunity to orient a community of researchers around
common goals of understanding how to ideally study
neuroplasticity in the context of neurorehabilitation; it will
be a goal of our working group to advance these efforts.
Testing specific hypotheses about functional brain plasticity
after AMS-TBI Through the use of functional brain imaging
approaches (typically fMRI), investigators are frequently in-
terested in the basis of brain plasticity, commonly referred to
as neural “reorganization” , fol lowing AMS-TBI.
Reorganization is often loosely applied to refer to the broad
class of anatomical structural and functional alterations in the
human brain when performing behavioral tasks after TBI. For
some changes post-AMS-TBI, terms such as “compensation”
are often used interchangeably with reorganization which has
led to confusion and even controversy (see Hillary 2011;
Turner et al. 2011). However, it is possible to define a priori
hypotheses that predict what functional changes are associated
with which theories of anatomical and functional remodeling
in the brain (Hillary 2008; Hillary et al. 2006; Medaglia 2017;
Medaglia et al. 2012; Olsen et al. 2015; Turkeltaub, in press;
Venkatesan and Hillary 2019) and even integrate alternative
methods including EEG and DTI to examine mechanisms of
increased frontal activation commonly observed in TBI (see
Olsen et al. 2020). It is further important to use brain-behavior
analyses that distinguish competing theories of dysfunction
from those of adaptive neuroplasticity. What is required is
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additional power to examine distinct clinical subgroupings
and how systems-level plasticity alters behavioral outcome.
ENIGMA will provide a platform to support well-powered
studies that refine and systematically examine brain reorgani-
zation hypotheses in AMS-TBI.
With the emergence of network neuroscience, analyses of
functional MRI data now often include network analyses and
a number of studies have focused on how msTBI alters dis-
tributed neural systems using graph theory and other ap-
proaches (for a review, see Caeyenberghs et al. 2017).
Several useful heuristics have emerged from this literature
including the observation that TBI may result in enhanced
connectivity, or hyperconnectivity (see for a review Hillary
and Grafman 2017; Hillary et al. 2015) but this is juxtaposed
to other studies documenting disruption in large-scale net-
works, including the default mode network and salience net-
work as fundamental to problems with set-shifting and atten-
tion (see Bonnelle et al. 2012, 2011; Jilka et al. 2014). Thus,
while hyperconnectivity has been demonstrated during recov-
ery (<1 year post injury; Bernier et al. 2017; Hillary et al.
2014; Nakamura et al. 2009) and in chronic TBI subjects
(see Palacios et al. 2012; Sharp et al. 2011; Venkatesan et al.
2015), the finding is clearly not universal (see Sharp et al.
2014). Clarification is needed, and can be achieved by
leveraging large samples that are well-defined with regard to
age at injury, time-post injury, and other clinical indicators;
such scale and detail may facilitate the exploration of the cir-
cumstances where hyperconnectivity is present and its possi-
ble associations with clinical outcome.
Chronic msTBI, aging and risk for neurodegeneration Efforts
are currently underway within the working group for un-
derstanding the chronic and long-term effects of TBI on
patient functioning. This area of work has gained signifi-
cant attention over the past decade as there has been in-
creased interest in understanding TBI as a chronic health
condition (Corrigan and Hammond 2013). The link be-
tween TBI and dementia is supported by some large cohort
studies (Guo et al. 2000; Plassman et al. 2000) including
the demonstration of a dose-response relationship between
injury severity and increased risk of Alzheimer’s disease
and dementia. Other studies have not found this associa-
tion (Weiner et al. 2017). However, there is evidence for
broader links between TBI and neurodegeneration, includ-
ing microinfarcts, synucleinopathies and Parkinson’s dis-
ease (Crane et al. 2016; Dams-O’Connor et al. 2016).
Multiple mechanisms have been suggested to explain
how TBI may be linked to neurodegeneration, including
impaired immune function/inflammation (Jassam et al.
2017; Wagner and Kumar 2019) increased vascular risk
which has strong links to neurodegeneration (Sweeney et
al. 2018; Zlokovic 2011) and alterations in large-scale neu-
ral networks leading to disconnection (Hillary and
Grafman 2017; Jones et al. 2016). In vivo neuroimaging
tools can contribute substantially to the understanding of
mechanistic links between TBI and neurodegeneration.
There is a critical need to examine processes that reflect
the phenomenon of “aging-with-TBI” and addressing this
issue has become a priority in the study of TBI (see
National Institute of Neurological Disorders and Stroke
2018). Considerable investments have been made in char-
acterizing the pathological sequelae of repetitive
“subconcussive” head trauma (Hirad et al. 2019; McKee
et al. 2016) and some efforts are underway to help charac-
terize the clinical correlates of this pathology; however,
AMS-TBI is inexplicably excluded from currently pro-
posed case definitions of traumatic encephalopathy syn-
drome (Montenigro et al. 2014; Reams et al. 2016). As
such, the community of AMS-TBI researchers is charged
with: 1) establishing a shared nomenclature and operation-
al definition of post-traumatic dementia in AMS-TBI, and
2) common methods and data sharing approaches specific
to AMS-TBI so that imaging can be leveraged to advance
discovery. Given this background, early efforts for the
AMS-TBI working group will be to support data harmoni-
zation, analyses and, ultimately, prospective data collec-
tion for detailed analysis of mechanism for neurodegener-
ative risk in msTBI. Novel analysis techniques may also
help to interpret longitudinal changes as well as help pre-
dict ongoing trajectories of change. For example, there is a
literature using functional MRI (Crone et al. 2018; Hillary
et al. 2014; Rajtmajer et al. 2015; Roy et al. 2016), struc-
tural (Lutkenhoff et al. 2013, 2019), and multimodal data
(e.g., structural MRI and EEG; Schnakers et al. 2019) to
examine recovery in small samples of AMS-TBI during the
first year post injury, but we also need more robust
methods tailored for more long-term consequences of
TBI (Cruz-Haces et al. 2017) which can also handle het-
erogeneous outcome trajectories. We anticipate that inter-
national collaborations, with careful meta-analysis of data
from multiple centers, will provide novel avenues for ex-
ploring and clarifying chronic and long-term effects of
TBI.
Integration of MRI data with other imaging techniques and
non-imaging biomarkersWhile the focus of ENIGMA AMS-
TBI is on imaging and particularlyMRI methods, there is now
substantial evidence that no existing single imaging modality
or diagnostic /neuromonitoring tool is sufficient for character-
ization and phenotyping in TBI (Amyot et al. 2015; Mondello
et al. 2018a). The logical next step is to identify a multidimen-
sional profile employing distinct classes of emerging technol-
ogies that convey diverse, complementary and independent
information thereby enabling clinicians to achieve better char-
acterization of patients with TBI and stratify risk more effec-
tively. Such strategy is likely to provide a greatly expanded
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understanding of the pathogenesis and consequences of TBI,
making it possible to transform health care delivery and im-
prove patient outcomes by individualizing management and
intervention. Future directions of our working group relying
on the synergy of multidisciplinary collaboration will there-
fore entail focus on the development of novel methods for
robust integration of different advanced neuromonitoring
tools in our large-scale imaging analyses. Current participat-
ing sites have datasets including PET imaging, MRS, EEG, as
well as fluid biomarkers.
PET imaging has been used to assess early injury mecha-
nisms (Bergsneider et al. 2001; Coles et al. 2004), recovery
(Yamaki et al. 2018), long-term neural consequence (Barrio et
al. 2015; Bodart et al. 2017; Lupi et al. 2011) and neural
correlates of functional deficits (Buchsbaum et al. 2015;
García-Panach et al. 2011; Komura et al. 2019; Nakashima
et al. 2007; Spadoni et al. 2015) or interventions (Östberg et al.
2018; Scott et al. 2018). PET is a valuable approach for meth-
odological corroboration of structure and functional brain re-
sults and can elucidate TBI pathophysiology in a manner not
possible with MRI or CT. For example, one current hypothe-
sis regarding the role of increased connectivity following TBI
(i.e., hyperconnectivity) is that while potentially “compensa-
tory” for function, enhancement of functional connections has
longer term metabolic costs resulting in pathological protein
aggregation (Hillary and Grafman 2017). With metabolic im-
aging this hypothesis can be evaluated directly. Tau deposi-
tion has more recently been observed in mixed TBI samples
(see Gorgoraptis et al. 2019; Wooten et al. 2019). In the work
by Wooten and colleagues, these findings where spatially co-
localized with sites showing the greatest network connectivity
established using fMRI. [C-11] PiB PET has also demonstrat-
ed amyloid aggregation in msTBI (Hong et al. 2014; Scott et
al. 2016), recapitulating the temporal pattern seen in post
mortem findings, and demonstrating specific early striatal de-
position not detected by autopsy studies. Finally, there are
now tracers targeting activated microglia (Coughlin et al.
2015; Scott et al. 2018) which permit examination of the
shifting balance between pro- and anti-inflammatory process-
es induced by microglial activation that allow for restoration
rather than perpetuation of injury (Sandvig et al. 2018) and
thus potentially improve TBI outcome. Combining PET and
MRI data has a great potential to advance the understanding of
the primary and secondary pathophysiological mechanisms in
TBI and future efforts in our working group will be focused on
this vital integration of data types.
Magnetic resonance spectroscopy (MRS) is (unlike PET) a
noninvasive tool to measure brain metabolites that are indica-
tive of injury. MRS has shown alterations in metabolites
reflecting neuronal health and cellular turnover in TBI
(Bartnik-Olson et al. 2019; Brown et al. 2018). Whole brain
N-acetylaspartate (NAA), which is a proxy for neuronal
integrity, and choline (Cho), a cell membrane marker, correlate
with injury severity and neuropsychological functioning
(Govind et al. 2010; Govindaraju et al. 2004; Maudsley et al.
2015), as well as with coarse global outcomes (GOS) at
3 months post injury (Marino et al. 2007). Across all severity
ranges, the predictive utility of MRS for long-term functioning
is above and beyond other clinical indicators and conventional
structural imaging findings. Since our working group will in-
clude several additional imaging modalities, the unique contri-
bution of MRS to help elucidate the pathobiology imaged by
these other modalities (structural and functional) can be lever-
aged further.
Electroencephalography (EEG) is a non-invasive tech-
nique that can provide valuable information about sensory
and higher order cognitive processing after TBI. Sensory
evoked potentials can provide vital information related to the
integrity and functionality of peripheral pathways and spinal
tracts (Carter and Butt 2005; Munjal et al. 2010). Other uses of
EEG include the assessment of the level of consciousness in
patients with AMS-TBI who lack behavioral evidence of lan-
guage expression and comprehension (Braiman et al. 2018;
Cruse et al. 2011; Edlow et al. 2017). The power and power
variability of different frequency bands at an early stage after
injury (1–10 days in most studies) has been linked to global
outcome (typically GOSE 6 months after injury; see Hebb et
al. 2007; Schnakers et al. 2019; Tolonen et al. 2018; Vespa et
al. 2002). Moreover, the amplitude and latency of event relat-
ed potentials (ERPs) can support inferences about the nature
of specific cognitive impairments (e.g. processing speed,
sustained attention, performance monitoring and inhibitory
control; see reviews by (Dockree and Robertson 2011;
Duncan et al. 2005; Folmer et al. 2011). Currently, there are
few studies in AMS-TBI combining EEG and advanced neu-
roimaging techniques. One recent example of a study combin-
ing EEG with MRI and DTI demonstrated a link between
higher neuronal synchrony during sleep and white matter
damage in frontal and temporal brain regions (Sanchez et al.
2019). Our working group will collaborate with the
ENIGMA-EEG working group to leverage the full potential
of combining EEG data with other imaging techniques in
msTBI.
Fluid biomarkers have emerged as an objective and power-
ful tool for aiding clinical diagnosis, monitoring the progression
of damage or response to treatment, serving as surrogates of
clinical outcomes and characterizing pathogenic mechanisms
and potential therapeutic targets in patients with TBI
(Mondello et al. 2018b; Undén et al. 2013). Such potential
has dramatically stimulated the quest for new markers and ac-
celerated their integration into clinical decision rules (Mondello
et al. 2018b; Undén et al. 2013). Moreover, to better account for
the complexity of the molecular, biologic and pathologic events
triggered by the injury, an intense effort is underway to expand
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biomarker role and integrate them into novel sophisticated ap-
proaches of multidimensional classification of TBI (Ko et al.
2019; Nielson et al. 2017; Thelin et al. 2017).
Examination of advanced MRI data in relation to glial and
neuronal markers in blood has shown that acute assessment of
glial fibrillary acidic protein [GFAP] correlates closely with in-
tracranial bleeding as assessed by susceptibility weighted imag-
ing (SWI) but not with other imaging techniques (Kou et al.
2013). More recently, extending and corroborating this research,
Gorgoraptis and colleagues (Gorgoraptis et al. 2019) have re-
ported in individuals who have suffered a moderate to severe
TBI an association between PET data, MRI correlates and CSF
markers of neurodegeneration (Tau and ubiquitin carboxy-
terminal hydrolase L1 [UCH-L1]) many years after the injury,
concluding that increased flortaucipir (i.e. a radioligand for tau)
binding is indicative of the presence of tau pathology and trau-
matic axonal injury which are, in turn, interconnected. Taken
together, these observations emphasize the usefulness of com-
parative analysis between fluid biomarker and neuroimaging to
solve interpretative problems and comprehensively understand
the molecular mechanisms and pathogenesis of the observed
damage, tying different features (quantification, distribution, ki-
netics), and neuropathological conditions (e.g. tau deposition,
macromorphological and micro-structural changes of white and
grey matter) to underlying biomarkers profiles and disease pro-
cesses (e.g. neuronal loss, axonal injury and progressive neuro-
degeneration). It is, therefore, tempting to speculate that this
approach creates the opportunity for identifying specific -
possibly unique- multimodal signatures of TBI and represents
a “new paradigm of hypothesis-generating research”.
Despite the recently developed sensitive and high-
sensitivity assays that have been shown to improve the diag-
nostic accuracy of TBI complementing neuroimaging tech-
niques, to date, operational strategies to best take advantage
of these tests in clinical practice are limited. Two clinical stud-
ies (Gill et al. 2018; Yue et al. 2019) by independent groups
have demonstrated in large cohorts that analysis of blood
GFAP concentrations can identify patients with TBI who
might need subsequent MRI examination. These findings pave
the way for the incorporation of GFAP into clinical algorithms
for diagnostic workup strategy selection. Furthermore, combin-
ing fluid and imaging biomarkers may also turn into valuable
means to understand treatment mechanisms and evaluate even-
tual therapeutic interventions. To this end, a recent study has
shown that the combination of PET, MRI and NFL provides
unique information for better understanding the effects of
minocycline on microglial activation (Scott et al. 2018).
Despite these promising examples, this work is still in its
infancy. Further validation, standardization and evidence of
clinical utility beyond current practice standards is needed.
In this regard, ENIGMA AMS-TBI can contribute important-
ly to this growing base of evidence by 1) identifying and
unveiling the relationships between advanced imaging
techniques, fluid biomarker and clinical outcomes, 2) demon-
strating and validating the added value (e.g. improved damage
characterization, quantification) when combining these differ-
ent tools, and 3) determining the context in which the conclu-
sions apply (i.e. clinical utility for a specific contextual use).
ENIGMA AMS-TBI is also uniquely suited for playing an
instrumental role in developing and defining clinical algo-
rithms and recommendations/guidelines which identify the
best practices integrating biofluid and imaging markers for
the diagnosis, prognosis, and management/treatment of pa-
tients with msTBI. Finally, if successfully implemented, this
research framework could be adopted as a blueprint across
other neurological and neurodegenerative disorders.
Harnessing the power of radiogenomics in msTBI Genetic
factors modulate host-response and secondary injury after
TBI, and may therefore account for some of the unexplained
variation in outcome (Maas et al. 2017). Much existing liter-
ature has focused on the impact of genetics in mild injury
(McFadyen et al. 2019; Nielson et al. 2017; Winkler et al.
2017) or on global clinical outcome (Conley et al. 2014;
Dardiotis et al. 2014; Failla et al. 2015a). However, (other)
reports in msTBI have explored the relationships between
genetics (particularly single nucleotide polymorphisms) and
more granular pathophysiology-based outcomes such as cog-
nition (Ariza et al. 2006; Failla et al. 2015b; Isoniemi et al.
2006; Koponen et al. 2004; Krueger et al. 2011; Markos et al.
2017; McFadyen et al. 2019; Nicoll et al. 1995; Wagner et al.
2012), seizures (Darrah et al. 2013; Diamond et al. 2015;
Diaz-Arrastia et al. 2003; Ritter et al. 2016; Wagner et al.
2010; Wang et al. 2017), cerebral autoregulation and blood
flow (Chen et al. 2011; Robertson et al. 2011), cerebral edema
(Jha et al. 2019, 2018, 2017), and contusion expansion
(Hadjigeorgiou et al. 2005; Liaquat et al. 2002). While many
of these genetic association analyses have used neuroimaging
metrics, the more common use of structural and functional
neuroimaging as endophenotypes of outcome (Coughlin et
al. 2017, 2015; De Simoni et al. 2016; Hong et al. 2014;
Lutkenhoff et al. 2015; Newcombe et al. 2016, 2013;
Schnakers et al. 2019; Scott et al. 2016; Stender et al. 2014;
Veenith et al. 2014; Zheng et al. 2017) have been less well
studied in the context of studies evaluating the genetic influ-
ence on disease process after msTBI. Global TBI outcomes
are complex and multifaceted, and the role of genetic variation
on eventual outcome, months to years after injury, may be
confounded by multiple intrinsic and extrinsic factors. These
difficulties may be mitigated by better understanding of the
molecular mechanisms that underpin secondary injury, and
identifying candidate imaging phenotypes which can be ratio-
nally related to these processes. Thus, genetic determinants of
cerebral edema, late neurodegeneration, or neuroplasticity (all
of which have imaging phenotypes that are discussed else-
where in this manuscript) may differ from one another in
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effect (identity and/or direction). Thesemore specific outcomes
may show detectable genetic associations which are diluted or
undetectable in studies evaluating global clinical outcome.
Clinical radiogenomics (the correlation of genetic signa-
tures with imaging) was pioneered in tumor biology research,
where it has informed treatment and prognostication (for
review see Pinker et al. 2018). Although less commonly used
in TBI, this approach has been applied to imaging phenotypes
in TBI, (Table 1) leveraging knowledge of underlying molec-
ular mechanisms to direct investigation of specific genes/path-
ways. However, such studies are limited by small sample sizes
which lack the statistical power to detect rare (but mechanis-
tically important) genetic variations, or to validate them in
unbiased genome-wide association studies (GWAS).
Although multicenter consortia (such as CENTER-TBI and
TRACK-TBI) are beginning to deliver the sample sizes need-
ed, radiogenomic research in msTBI is challenged by the time
and cost of acquiring imaging datasets, differences in image
acquisition across centers, failure of conventional image pro-
cessing tools in severely injured brains, and variations in data
processing and access to genetic data across research groups.
A collaborative, standardized and accessible platform for
researchers to process, integrate, harmonize, optimize, analyze
and disseminate imaging phenotypes is thus imperative to
advance fundamental knowledge about the impact of genetics
on imaging metrics of disease biology and outcome after TBI.
ENIGMA will provide such a framework to leverage imag-
ing and genomic data obtained from existing multicenter initia-
tives, single center datasets, and future studies. This will facili-
tate research evaluating effects of genetic variation (mutations,
gene expression, epigenetics, pathway analyses) on distinct
pathophysiological processes, using imaging metrics as pheno-
types for association. This could deliver better understanding of
disease biology and identify new druggable molecular targets.
Combining genetic profiles and imaging features also has pow-
erful synergistic potential in terms of risk stratification and pre-
cision medicine, providing opportunities for early, targeted in-
tervention and prognostication (Fig. 5). For example, despite
extensive study of APOE-e4 genotypes in TBI, its precise rela-
tionship with modulating outcomes is undefined (for review see
McFadyen et al. 2019). Complementing genotype data with
serial PiB PET imaging characteristics may provide pathophys-
iologic insight and improve prediction of risk for post-traumatic
Alzheimer’s Disease (Fig. 5).
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Fig. 5 Future vision of radiogenomics in moderate/severe TBI. This
schematic demonstrates relationships between genetic signatures,
imaging characteristics, and endophenotype outcomes after msTBI.
Genetic signatures can be in the form of mutations, regulation,
expression profiles, and epigenetics for single-genes or pathways.
Different genetic signatures impact specific outcome phenotypes (for
example: neurodegeneration/cognition, seizures, cerebral edema, neural
regeneration). Some of these outcome endophenotypes may be detected
acutely (e.g. cerebral edema), whereas others may have a temporal lag
varying from days-years until clinical detection (seizures,
neurodegeneration). Imaging features may serve as surrogates for
certain outcome endophenotypes- for example, MRI based ADC
hypointensity may reflect cytotoxic edema, or PiB detection of amyloid
aggregationmay portend risk for Alzheimer’s Disease. Genetic signatures
can thus be linked to imaging features as proxies for an endophenotypic
outcome, or interpreted synergistically. Hypothetical example 1 (blue)
suggests that a specific APOE e4 genotype (blue-1, genetic signature)
results in a certain PiB-PET profile (blue-2, imaging feature); these two
features combined may predict risk of post-traumatic Alzheimer’s type
dementia (blue-3, endophenotype outcome). Hypothetical example 2
(red) indicates that detection of perihematomal ADC reduction (red-1,
imaging feature) reflects a specific ABCC8:TRPM4 haplotype (red-2,
genetic signature); this haplotype impacts risk of malignant cerebral
edema and mediates response to therapy. (Of note, ABCC8 and
TRPM4 encode subunits of an octameric cation channel known to
mediate cerebral edema after brain injury). Identifying the relationship
between genetic signatures, imaging features, and outcome
endophenotypes for different secondary injury processes will facilitate
precision medicine, identification of novel targets, opportunities for
early intervention, risk stratification and prognostication, ABCC8 =
ATP binding cassette subfamily C member-8; ADC = apparent
diffusion coefficient; APOE-e4 = apolipoprotein E epsilon 4; MRI =
magnetic resonance imaging; msTBI = moderate-severe TBI; PET =
positron emission tomography, PiB = Pittsburgh compound B,
TRPM4 = transient receptor potential cation channel subfamily M.
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Conclusion
The ENIGMAAMS-TBIworking groupwas recently initiated to
address an unmet need for a robust framework to leverage imag-
ing data in AMS-TBI research. Here we have outlined the back-
ground and structure of ENIGMA AMS-TBI, roles of investiga-
tors and our short, intermediate and long-term goals. The ap-
proaches and initiatives within the group will be shaped by the
joint efforts of existing and future new members. We encourage
researchers who are interested in contributing to this work to
contact the authors of this paper to join our efforts toward a global
and reproducible science for brain imaging in neurotrauma.
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